Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 0.55 |
| ▸ | CA2 | P00918 | 5/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | EEF2K | O00418 | 2/20 | 0.41 |
| ▸ | EEF2 | P13639 | 2/20 | 0.41 |
| ▸ | PLK4 | O00444 | 1/20 | 0.41 |
| ▸ | JAK2 | O60674 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | TYK2 | P29597 | 1/20 | 0.41 |
| ▸ | FLT3 | P36888 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | ITK | Q08881 | 1/20 | 0.41 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28416359 | 1.00 | CA1 (0.55) | CA1CA2MEN1KMT2AEEF2K | |
| SCHEMBL5077157 | 1.00 | CA1 (0.55) | CA1CA2MEN1KMT2AEEF2K | |
| SCHEMBL5682591 | 1.00 | CA1 (0.55) | CA1CA2MEN1KMT2AEEF2K | |
| SCHEMBL6434689 | 1.00 | CA1 (0.55) | CA1CA2MEN1KMT2AEEF2K | |
| Bromide SCHEMBL1329494 | 0.98 | CA1 (0.57) | CA1CA2MEN1KMT2AEEF2K | |
| Bromide SCHEMBL1330852 | 0.98 | CA1 (0.54) | CA1CA2MEN1KMT2AEEF2K | |
| Bromide SCHEMBL1330725 | 0.98 | CA1 (0.57) | CA1CA2MEN1KMT2AEEF2K | |
| Bromide SCHEMBL1330860 | 0.98 | CA1 (0.57) | CA1CA2MEN1KMT2AEEF2K | |
| Bromide SCHEMBL1330831 | 0.98 | CA1 (0.57) | CA1CA2MEN1KMT2AEEF2K | |
| Bromide SCHEMBL1329489 | 0.98 | CA1 (0.54) | CA1CA2MEN1KMT2AEEF2K |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115745946-A | Low-temperature preparation method of glycolide-lactide | 中国科学院长春应用化学研究所 | 2023-03-07 | — | — | CN | claimed |
| CN-112661779-B | Biosynthesis method and application of N-methyl o-carborane-L-propionamide | 南京艾斯特医药科技有限公司 | 2022-09-20 | — | — | CN | claimed |
| CN-112239698-B | By Fe3O4Method for fixing ionic liquid lubricating film by @ C core-shell nano nail | 南京理工大学 | 2022-03-25 | — | — | CN | claimed |
| US-20210395906-A1 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | CUSTOMARRAY INC (US) | 2021-12-23 | — | — | US | claimed |
| CN-109465013-B | Modified skeleton iron catalyst and method for preparing citronellol by selectively hydrogenating citral | 万华化学集团股份有限公司 | 2021-09-07 | — | — | CN | claimed |
| CN-112661779-A | Biosynthesis method and application of N-methyl o-carborane-L-propionamide | 南京艾斯特医药科技有限公司 | 2021-04-16 | — | — | CN | claimed |
| CN-112239698-A | By Fe3O4Method for fixing ionic liquid lubricating film by @ C core-shell nano nail | 南京理工大学 | 2021-01-19 | — | — | CN | claimed |
| US-9004817-B2 | Soil remediation systems and methods | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2015-04-14 | — | — | US | claimed |
| US-20130341561-A1 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | CUSTOMARRAY, INC. (US) | 2013-12-26 | — | — | US | claimed |
| US-20120263538-A1 | SOIL REMEDIATION SYSTEMS AND METHODS | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2012-10-18 | — | — | US | claimed |
| WO-2012085964-A1 | SOIL REMEDIATION SYSTEMS AND METHODS | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2012-06-28 | — | — | WO | claimed |
| US-8083945-B2 | Fluid storage and purification method and system | MATHESON TRI-GAS, INC. (US) | 2011-12-27 | — | — | US | claimed |
| US-20100223208-A1 | FLUID STORAGE AND PURIFICATION METHOD AND SYSTEM | MATHESON TRI-GAS, INC. (US) | 2010-09-02 | — | — | US | claimed |
| US-7718579-B2 | Electrochemical deblocking using a hydrazine derivative | COMBIMATRIX CORPORATION (US) | 2010-05-18 | — | — | US | claimed |
| EP-1869061-A2 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | Combimatrix Corporation (US) | 2007-12-26 | — | — | EP | claimed |
| EP-1805206-A2 | ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE | Combimatrix Corporation (US) | 2007-07-11 | — | — | EP | claimed |
| US-20070034513-A1 | Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array | COMBIMATRIX CORPORATION | 2007-02-15 | — | — | US | claimed |
| WO-2006105037-A2 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | COMBIMATRIX CORPORATION (US) | 2006-10-05 | — | — | WO | claimed |
| WO-2006031814-A2 | ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE | COMBIMATRIX CORPORATION (US) | 2006-03-23 | — | — | WO | claimed |
| US-20060054511-A1 | Electrochemical deblocking using a hydrazine derivative | CUSTOMARRAY, INC. | 2006-03-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210395906-A1 | ELECTROCHEMICAL DEBLOCKING SOLUTION FOR ELECTROCHEMICAL OLIGOMER SYNTHESIS ON AN ELECTRODE ARRAY | DNMT1, DNASE1, DNPEP | CA1 195/4885CA2 1004/4885MEN1 1771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.